Skip to main content
. 2022 Oct 28;11(11):1250. doi: 10.3390/pathogens11111250

Table 1.

Demographic and clinical characteristics of COVID-19 patients with and without co-infection.

Variables COVID-19 Patients without Co-Infection
n = 267
COVID-19 Patients with Co-Infection n = 43 p-Value
Gender % (n)
Male 69.2 (185) 74.4 (32) 0.043 *
Female 30.8 (82) 25.6 (11)
Mean age, years 63.3 (48–80) 61.2 (50–77) 0.975
Length of hospitalization (median,IQR), days 12 (5–15) 14 (6–17) 0.522
Any comorbidities % (n)
Hypertension 45.7 (122) 48.8 (21) 0.865
Ischemic Heart Disease 25.8 (69) 25.6 (11) 0.989
Diabetes Mellitus 24.3 (65) 27.9 (12) 0.517
Coronary Insufficiency 18.3 (49) 11.6 (5) 0.241
Smoking history 11.6 (31) 13.9 (6) 0.062 *
Obesity 10.1 (27) 13.9 (6) 0.035 *
Pulmonary diseases 8.6 (23) 11.6 (5) 0.412
Chronic kidney disease 7.1 (19) 6.9 (3) 0.908
Neoplasy 5.9 (16) 4.6 (2) 0.476
Cirrose 0 (0) 0 (0) -
Human Immunodeficiency Virus 0 (0) 0 (0) -
Symptoms
Fever 82.7 (221) 86.0 (37) 0.123
Dyspnea 83.1 (222) 81.4 (35) 0.563
Cough 62.9 (168) 67.4 (29) 0.346
Diarrhea 14.2 (38) 11.6 (5) 0.322
Vomiting 5.6 (15) 4.6 (2) 0.645
Chest pain 2.9 (8) 2.3 (1) 0.675
Pharyngitis 2.6 (7) 2.3 (1) 0.908
Anosmia and/or Dysgeusia 1.5 (4) 2.3 (1) 0.238
Dizziness 0 (0) - -
Rhinorrhea 0 (0) - -
Asymptomatic 2.2 (6) - -
Signs
Systolic arterial pressure, mm Hg 132.4 (120–140) 110 (110–120) 0.509
Diastolic arterial pressure, mm Hg 76 (70–80) 70 (70–80) 0.873
Heart rate, bpm 85.8 (27.2–92) 80 (30–90) 0.242
Respiratory rate, rpm 21.3 (17.5–24.5) 22.8 (21–23) 0.482

* p-value ≤ 0.05 was considered statistically significant.